WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
ICLR
ICON PLC
$24.81B7.50%4.00%7.31%20.70%0.811.2129.60%8.30%12.52%
FONR
FONAR CORP
$113.14M7.60%6.10%8.95%10.30%0.289.3545.70%11.90%16.44%
STRR
STAR EQUITY HOLDINGS INC
$13.91M42.40%31.80%35.27%72.30%0.163.9926.00%50.70%51.43%
RVTY
REVVITY INC
$12.61B8.80%5.00%6.72%14.30%0.722.0756.00%25.20%29.60%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$11.70B14.30%6.10%9.98%12.30%1.261.5336.40%11.50%17.25%
A
AGILENT TECHNOLOGIES INC
$39.96B21.20%11.50%15.26%24.30%0.772.6850.60%18.40%21.14%
NEOG
NEOGEN CORP
$2.59B0.00%0.00%1.64%5.10%0.463.8251.00%0.20%7.80%
QGEN
QIAGEN NV
$9.37B9.30%5.50%9.60%14.10%0.611.9962.80%17.40%24.59%
IDXX
IDEXX LABORATORIES INC
$40.65B71.70%28.10%47.77%44.50%1.201.5759.80%23.10%30.12%
TMO
THERMO FISHER SCIENTIFIC INC
$218.01B13.50%6.20%9.04%15.20%1.111.7639.90%14.00%17.86%
ENZ
ENZO BIOCHEM INC
$54.81M53.70%32.60%43.30%151.90%0.403.20112.30%254.30%249.49%
LH
LABORATORY CORP OF AMERICA HOLDINGS
$16.68B4.80%2.30%5.97%7.90%1.121.1727.70%3.40%6.63%
MEDP
MEDPACE HOLDINGS INC
$12.08B59.70%19.70%42.66%-710.00%1.670.7828.00%15.90%18.24%
DGX
QUEST DIAGNOSTICS INC
$15.04B13.30%6.20%10.77%16.40%1.160.9732.90%9.10%13.51%
CSTL
CASTLE BIOSCIENCES INC
$535.55M-14.90%-13.20%-14.14%-29.90%0.166.2079.50%-26.10%-26.10%
SHC
SOTERA HEALTH CO
$3.20B12.80%1.60%8.58%7.60%6.062.4255.00%4.90%23.72%
DHR
DANAHER CORP
$182.06B8.30%5.20%7.07%19.20%0.561.8558.40%19.50%23.73%
TWST
TWIST BIOSCIENCE CORP
$1.80B-32.00%-25.90%-30.65%-53.80%0.245.9835.80%-78.40%-77.98%
WAT
WATERS CORP
$18.26B75.00%15.10%21.76%22.10%3.022.2259.60%21.70%28.25%
MTD
METTLER TOLEDO INTERNATIONAL INC
$26.48B-852.80%23.50%48.34%31.20%-23.381.0459.20%20.80%27.75%
SERA
SERA PROGNOSTICS INC
$335.28M-45.70%-37.40%-50.97%-56.70%0.362.5131.40%-11,843.80%-11,825.82%
IQV
IQVIA HOLDINGS INC
$42.47B23.00%5.20%10.55%16.60%3.370.8635.00%9.10%14.22%
EXAS
EXACT SCIENCES CORP
$10.67B-6.60%-3.20%-3.06%-5.00%1.062.3273.80%-8.20%-7.29%
XGN
EXAGEN INC
$24.30M-80.30%-36.30%-47.34%-47.60%1.514.0256.10%-45.10%-40.57%
PSNL
PERSONALIS INC
$63.13M-66.60%-44.50%-60.78%-64.10%0.743.1124.80%-147.40%-147.12%
PRPO
PRECIPIO INC
$8.83M-42.10%-30.80%-39.00%-958.50%0.251.1739.60%-38.50%-38.40%
NTRA
NATERA INC
$11.02B-62.20%-31.90%-37.19%-43.00%0.884.1045.50%-40.20%-38.97%
OLK
OLINK HOLDING AB (PUBL)
$2.87B-6.50%-5.60%-7.14%-27.00%0.204.7567.50%-18.60%-23.02%
FLGT
FULGENT GENETICS INC
$596.59M-13.60%-12.60%-14.34%-17.80%0.096.9636.10%-58.00%-57.63%
DRIO
DARIOHEALTH CORP
$43.28M-91.80%-59.30%-70.76%-181.70%0.663.7929.40%-312.10%-291.68%
ACRS
ACLARIS THERAPEUTICS INC
$84.40M-52.80%-40.20%-53.38%-58.50%0.264.1642.10%-283.10%-284.32%
GH
GUARDANT HEALTH INC
$2.09B-301.90%-27.70%-30.13%-20.50%10.266.5459.70%-85.00%-84.44%
STIM
NEURONETICS INC
$104.74M-72.80%-29.30%-25.79%-29.70%2.394.7372.50%-42.30%-34.71%
NEO
NEOGENOMICS INC
$1.77B-9.20%-5.20%-5.69%-9.10%0.796.2041.30%-14.90%-15.24%
DMTK
DERMTECH INC
$20.25M-124.00%-67.90%-93.00%-69.90%1.134.591.80%-659.60%-659.57%
BNR
BURNING ROCK BIOTECH LTD
$87.04M-71.70%-52.80%-83.86%-261.80%0.353.3667.60%-121.60%-121.19%
OCX
ONCOCYTE CORP
$20.19M-82.30%-35.20%-40.96%-523.20%2.411.4927.50%-1,911.00%-1,844.91%
RDNT
RADNET INC
$3.35B0.60%0.10%3.37%2.80%2.981.3213.70%0.20%4.70%
BGLC
BIONEXUS GENE LAB CORP
$10.48M-33.00%-27.00%-26.55%-42.20%0.184.9313.60%-26.90%-26.54%
LAB
STANDARD BIOTOOLS INC
$684.68MN/A-21.50%-32.58%-39.50%-1.081.4547.40%-70.20%-65.49%
PRE
PRENETICS GLOBAL LTD
$60.21M-28.70%-22.80%-29.34%-80.70%0.212.3740.60%-288.50%-289.72%
APDN
APPLIED DNA SCIENCES INC
$4.24M-110.20%-49.80%-98.41%-310.50%1.371.7737.60%-81.00%-80.13%
XWEL
XWELL INC
$7.53M-115.00%-54.70%-93.40%-68.20%1.392.8512.20%-92.10%-92.02%
BDSX
BIODESIX INC
$122.15M-30,185.80%-60.60%-64.88%-71.00%20.641.1973.50%-106.20%-86.81%
CDNA
CAREDX INC
$391.45M-51.40%-37.80%-51.96%-69.10%0.794.0263.60%-67.90%-72.06%
MDXH
MDXHEALTH SA
$6.68M-192.90%-30.90%-24.93%-27.10%16.921.9662.60%-61.40%-38.93%
CHEK
CHECK-CAP LTD
$13.28M-51.90%-47.10%-70.88%-69.30%0.0617.60N/AN/AN/A
ME
23ANDME HOLDING CO
$221.66M-87.30%-64.80%-112.60%-534.30%0.612.1545.30%-210.50%-210.72%
NDRA
ENDRA LIFE SCIENCES INC
$2.67M-180.60%-133.00%-171.94%-341.40%0.193.36N/AN/AN/A
ULS
UL SOLUTIONS INC
N/AN/AN/A18.01%N/A3.151.3447.80%9.70%13.63%
PRPH
PROPHASE LABS INC
$89.32M-29.80%-18.10%-30.29%-30.70%0.862.2836.60%-37.80%-48.50%
AWH
ASPIRA WOMEN's HEALTH INC
$40.49MN/A-195.50%-1,460.19%-2,159.10%-3.651.0357.50%-182.30%-182.32%
OPK
OPKO HEALTH INC
$850.33M-12.80%-9.00%-9.43%-24.70%0.451.5536.80%-21.90%-19.79%
NOTV
INOTIV INC
$110.64M-12.40%-3.90%0.53%0.50%2.291.7430.30%-5.70%0.66%
VNRX
VOLITIONRX LTD
$73.04MN/A-154.20%903.04%391.60%-4.700.69100.00%-4,555.50%-4,526.94%
ISPC
ISPECIMEN INC
$2.54M-80.40%-62.00%-113.44%-227.60%0.621.3651.40%-111.80%-111.64%
GENE
GENETIC TECHNOLOGIES LTD
$503.22k-160.90%-105.50%-252.20%-5,353.20%0.761.6753.50%-150.00%-149.85%
MYGN
MYRIAD GENETICS INC
$1.62B-34.70%-22.60%-26.18%-61.20%0.462.0168.60%-35.00%-34.43%
BIAF
BIOAFFINITY TECHNOLOGIES INC
$27.75M-107.20%-84.10%-131.89%-540.30%0.691.7731.30%-313.40%-311.11%
PMD
PSYCHEMEDICS CORP
$14.59M-49.80%-27.40%-45.14%-34.10%0.851.4538.10%-18.80%-15.56%
ILMN
ILLUMINA INC
$19.23B-18.70%-10.60%-12.18%-23.70%0.761.6660.90%-25.80%-23.09%
MYNZ
MAINZ BIOMED NV
$18.14M-488.00%-145.80%-412.93%-1,525.40%3.740.9756.90%-2,936.50%-2,846.09%
TRIB
TRINITY BIOTECH PLC
$14.03MN/A-33.60%-29.33%-13.10%-3.482.6034.20%-42.30%-22.92%
MMA
ALTA GLOBAL GROUP LTD
N/AN/AN/A77.57%N/A-0.550.2285.00%-1,340.30%-1,049.23%
CNTG
CENTOGENE NV
$13.25M-1,921.20%-69.80%-113.83%-68.10%-5.721.4540.00%-111.50%-100.99%
TTOO
T2 BIOSYSTEMS INC
$15.10MN/A-135.40%209.48%-175.70%-2.240.45-113.60%-696.20%-621.91%

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 50, which is 22 points higher than the diagnostic & research industry average of 28. It passed 16 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 47.66% over the past year, overperforming other diagnostic & research stocks by 50 percentage points.

Icon has an average 1 year price target of $346.43, an upside of 15.45% from Icon's current stock price of $300.08.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Icon, 71.43% have issued a Strong Buy rating, 28.57% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the second best diagnostic & research stock with a Zen Score of 47, which is 19 points higher than the diagnostic & research industry average of 28. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 8.56% over the past year, overperforming other diagnostic & research stocks by 11 percentage points.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 14.03% over the past year, overperforming other diagnostic & research stocks by 16 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 3.12%, which is 2 percentage points higher than the diagnostic & research industry average of 1.38%.

Qiagen Nv's dividend payout ratio of 85.3% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.13%, which is 1 percentage points higher than the diagnostic & research industry average of 1.38%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.45%, which is the same as the diagnostic & research industry average of 1.38%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 60% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -1.46% in the last day, and up 3.15% over the last week. Laboratory Of America Holdings was the among the top losers in the diagnostics & research industry, dropping -4.61% yesterday.

Laboratory Corp shares are trading lower. The company reported Q1 financial results.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Icon has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Icon's stock has gained 47.66% in the past year. It has overperformed other stocks in the diagnostic & research industry by 50 percentage points.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 14.03% in the past year. It has overperformed other stocks in the diagnostic & research industry by 16 percentage points.

3. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -56.85% in the past year. It has underperformed other stocks in the diagnostic & research industry by -54 percentage points.

Are diagnostic & research stocks a good buy now?

48.94% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 11.37% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.32x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.